Literature DB >> 24164864

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Kevin Damman1, Mattia A E Valente, Adriaan A Voors, Christopher M O'Connor, Dirk J van Veldhuisen, Hans L Hillege.   

Abstract

AIMS: Chronic kidney disease (CKD) and worsening renal function (WRF) have been associated with poor outcome in heart failure (HF). METHODS AND
RESULTS: Articles were identified by literature search of MEDLINE (from inception to 1 July 2012) and Cochrane. We included studies on HF patients and mortality risk with CKD and/or WRF. In a secondary analysis, we selected studies investigating predictors of WRF. We retrieved 57 studies (1,076,104 patients) that investigated CKD and 28 studies (49,890 patients) that investigated WRF. The prevalence of CKD was 32% and associated with all-cause mortality: odds ratio (OR) 2.34, 95% confidence interval (CI) 2.20-2.50, P < 0.001). Worsening renal function was present in 23% and associated with unfavourable outcome (OR 1.81, 95% CI 1.55-2.12, P < 0.001). In multivariate analysis, moderate renal impairment: hazard ratio (HR) 1.59, 95% CI 1.49-1.69, P < 0.001, severe renal impairment, HR 2.17, 95% CI 1.95-2.40, P < 0.001, and WRF, HR 1.95, 95% CI 1.45-2.62, P < 0.001 were all independent predictors of mortality. Across studies, baseline CKD, history of hypertension and diabetes, age, and diuretic use were significant predictors for the occurrence of WRF.
CONCLUSION: Across all subgroups of patients with HF, CKD, and WRF are prevalent and associated with a strongly increased mortality risk, especially CKD. Specific conditions may predict the occurrence of WRF and thereby poor prognosis.

Entities:  

Keywords:  Heart failure; Prognosis; Renal failure; Worsening renal function

Mesh:

Year:  2013        PMID: 24164864     DOI: 10.1093/eurheartj/eht386

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  217 in total

Review 1.  The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.

Authors:  Bo Xiong; Yuwen Huang; Jie Tan; Yuanqing Yao; Chunbin Wang; Jun Qian; Shunkang Rong; Shimin Deng; Yin Cao; Yanke Zou; Jing Huang
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

2.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 3.  Synthesizing Markers of Kidney Injury in Acute Decompensated Heart Failure: Should We Even Keep Looking?

Authors:  Alexander S Manguba; Xavier Vela Parada; Steven G Coca; Anuradha Lala
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 4.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

5.  The impact of biventricular heart failure on outcomes after transcatheter aortic valve implantation.

Authors:  Tobias Schmidt; Mintje Bohné; Michael Schlüter; Mitsunobu Kitamura; Peter Wohlmuth; Dimitry Schewel; Jury Schewel; Michael Schmoeckel; Karl-Heinz Kuck; Christian Frerker
Journal:  Clin Res Cardiol       Date:  2018-12-03       Impact factor: 5.460

6.  Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study.

Authors:  Viera Stubnova; Ingrid Os; Morten Grundtvig; Dan Atar; Bård Waldum-Grevbo
Journal:  Cardiorenal Med       Date:  2017-01-20       Impact factor: 2.041

Review 7.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

8.  Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine.

Authors:  Attilio Losito; Emidio Nunzi; Loretta Pittavini; Ivano Zampi; Elena Zampi
Journal:  J Nephrol       Date:  2017-05-31       Impact factor: 3.902

Review 9.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

Review 10.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.